Recombinant anti-human IL-17A/F monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant anti-human IL-17A/F monoclonal antibody, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Anti-human IL-17A/F Humanized Monoclonal Antibody Injection in the Treatment of Moderate-to-Severe Active AS [Phase 3]